BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7507172)

  • 21. Protein folding pathways determined using disulphide bonds.
    Creighton TE
    Bioessays; 1992 Mar; 14(3):195-9. PubMed ID: 1285385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR characterization of partially folded and unfolded conformational ensembles of proteins.
    Barbar E
    Biopolymers; 1999; 51(3):191-207. PubMed ID: 10516571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of backbone dynamics in native BPTI: cooperative influence of the 14-38 disulfide and the Tyr35 side-chain.
    Beeser SA; Oas TG; Goldenberg DP
    J Mol Biol; 1998 Dec; 284(5):1581-96. PubMed ID: 9878372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
    Bulaj G; Goldenberg DP
    J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of a native-like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor.
    Staley JP; Kim PS
    Protein Sci; 1994 Oct; 3(10):1822-32. PubMed ID: 7531529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient catalysis of disulphide bond rearrangements by protein disulphide isomerase.
    Weissman JS; Kim PS
    Nature; 1993 Sep; 365(6442):185-8. PubMed ID: 7690463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of the conformational ensemble of partially folded bovine pancreatic trypsin inhibitor.
    Barbar E; Hare M; Daragan V; Barany G; Woodward C
    Biochemistry; 1998 May; 37(21):7822-33. PubMed ID: 9601043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR structural analysis of an analog of an intermediate formed in the rate-determining step of one pathway in the oxidative folding of bovine pancreatic ribonuclease A: automated analysis of 1H, 13C, and 15N resonance assignments for wild-type and [C65S, C72S] mutant forms.
    Shimotakahara S; Rios CB; Laity JH; Zimmerman DE; Scheraga HA; Montelione GT
    Biochemistry; 1997 Jun; 36(23):6915-29. PubMed ID: 9188686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding.
    Dadlez M; Kim PS
    Biochemistry; 1996 Dec; 35(50):16153-64. PubMed ID: 8973187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
    Kuroda Y; Kim PS
    J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-dimensional 1H nuclear magnetic resonance study of the (5-55) single-disulphide folding intermediate of bovine pancreatic trypsin inhibitor.
    van Mierlo CP; Darby NJ; Neuhaus D; Creighton TE
    J Mol Biol; 1991 Nov; 222(2):373-90. PubMed ID: 1960732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues. A chemical approach for evaluating the role of disulfide bridges in protein folding and stability.
    Ferrer M; Woodward C; Barany G
    Int J Pept Protein Res; 1992; 40(3-4):194-207. PubMed ID: 1282503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local structure due to an aromatic-amide interaction observed by 1H-nuclear magnetic resonance spectroscopy in peptides related to the N terminus of bovine pancreatic trypsin inhibitor.
    Kemmink J; van Mierlo CP; Scheek RM; Creighton TE
    J Mol Biol; 1993 Mar; 230(1):312-22. PubMed ID: 7680725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The partially folded conformation of the Cys-30 Cys-51 intermediate in the disulfide folding pathway of bovine pancreatic trypsin inhibitor.
    van Mierlo CP; Darby NJ; Creighton TE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6775-9. PubMed ID: 1379719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
    Kibria FM; Lees WJ
    J Am Chem Soc; 2008 Jan; 130(3):796-7. PubMed ID: 18166059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unfolding and refolding of the native structure of bovine pancreatic trypsin inhibitor studied by computer simulations.
    Hao MH; Pincus MR; Rackovsky S; Scheraga HA
    Biochemistry; 1993 Sep; 32(37):9614-31. PubMed ID: 7690589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformations of intermediates in the folding of the pancreatic trypsin inhibitor.
    States DJ; Creighton TE; Dobson CM; Karplus M
    J Mol Biol; 1987 Jun; 195(3):731-9. PubMed ID: 2443711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited proteolysis of bovine alpha-lactalbumin: isolation and characterization of protein domains.
    Polverino de Laureto P; Scaramella E; Frigo M; Wondrich FG; De Filippis V; Zambonin M; Fontana A
    Protein Sci; 1999 Nov; 8(11):2290-303. PubMed ID: 10595532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophobic interactions accelerate early stages of the folding of BPTI.
    Dadlez M
    Biochemistry; 1997 Mar; 36(10):2788-97. PubMed ID: 9062106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.